MAP2K7 and melanoma: Our previous studies (11,12) demonstrated that 1H and 31P MRS could noninvasively monitor key metabolic parameters, including lactate, alanine, pH, and bioenergetics (βNTP/Pi), to capture the effects of single-agent BRAF or MEK inhibition in human melanoma models.